NMPA Approval

Bupropion Hydrochloride Sustained-release Tablets(Ⅱ)

Approval Number

H20200003

CompanyGlaxoSmithKline GmbH & Co. KG

Registration Date

March 3, 2020

Drug Information

Generic Name

盐酸安非他酮缓释片(Ⅱ)

Dosage Form

片剂

Strength

150mg

Drug Type

化学药品

Registration Date

March 3, 2020

Expiry Date

March 2, 2025

Company Information

Applicant Company

Company NameGlaxoSmithKline GmbH & Co. KG

Company Address

Prinzregentenplatz 9,81675 Munich,Germany

Manufacturing Company

Company NameBausch Health

Company Address

100 LifeSciences Parkway, Steinbach, Manitoba, R5G 1Z7, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.